Renaissance Technologies’s Titan Pharmaceuticals TTNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.8K Buy
+11,380
New +$47.8K ﹤0.01% 3398
2024
Q4
Sell
-11,066
Closed -$58.3K 3923
2024
Q3
$58.3K Buy
+11,066
New +$58.3K ﹤0.01% 3329
2024
Q1
Sell
-6,766
Closed -$56K 4091
2023
Q4
$56K Sell
6,766
-20
-0.3% -$166 ﹤0.01% 3435
2023
Q3
$64K Buy
6,786
+5
+0.1% +$47 ﹤0.01% 3350
2023
Q2
$88K Buy
6,781
+10
+0.1% +$130 ﹤0.01% 3505
2023
Q1
$112K Buy
6,771
+50
+0.7% +$827 ﹤0.01% 3457
2022
Q4
$105K Sell
6,721
-515
-7% -$8.05K ﹤0.01% 3602
2022
Q3
$156K Sell
7,236
-4,800
-40% -$103K ﹤0.01% 3461
2022
Q2
$135K Buy
12,036
+10,210
+559% +$115K ﹤0.01% 3764
2022
Q1
$35K Buy
1,826
+850
+87% +$16.3K ﹤0.01% 3954
2021
Q4
$20K Buy
976
+326
+50% +$6.68K ﹤0.01% 3839
2021
Q3
$24K Buy
+650
New +$24K ﹤0.01% 3405
2020
Q1
Sell
-534
Closed -$62K 3801
2019
Q4
$62K Buy
+534
New +$62K ﹤0.01% 3374
2019
Q1
Sell
-72
Closed -$58K 3704
2018
Q4
$58K Sell
72
-124
-63% -$99.9K ﹤0.01% 3281
2018
Q3
$146K Buy
196
+16
+9% +$11.9K ﹤0.01% 3204
2018
Q2
$707K Buy
180
+13
+8% +$51.1K ﹤0.01% 2724
2018
Q1
$632K Buy
167
+14
+9% +$53K ﹤0.01% 2835
2017
Q4
$732K Buy
153
+31
+25% +$148K ﹤0.01% 2783
2017
Q3
$771K Buy
122
+45
+58% +$284K ﹤0.01% 2666
2017
Q2
$530K Buy
77
+11
+17% +$75.7K ﹤0.01% 2747
2017
Q1
$781K Buy
66
+25
+61% +$296K ﹤0.01% 2628
2016
Q4
$586K Buy
+41
New +$586K ﹤0.01% 2725
2016
Q1
Sell
-17
Closed -$275K 3534
2015
Q4
$275K Buy
+17
New +$275K ﹤0.01% 2910